05-BoNtA 568
05-BoNtA 568
05-BoNtA 568
Dr Philippe Deprez
Policlnica Esttica & anti aging National academy of Sciences Bucuresti Honour Member
BoNtA 568
Does not destroy axone Slows down Ach release in synaptic cleft Induces a transitory muscle relaxation
BoNtA 568 www.aestheticdermal.com 5
NO
Usual Botox-like products
Use only 1 oligopeptide (usually hexapeptide) In a low concentration ( 5 or 6% usually)
BoNtA 568
Uses 3 synergetic oligopeptides 3 x 20 % concentration in Medical Care 3 x 10 % concentration in Daily Care
BoNtA 568 www.aestheticdermal.com 6
BoNtA 568
Does not paralyse muscles like Botulinic toxin Uses a synergetic combination of 3 botox like oligopeptides in a much more concentrated way comparing to any other product of the market.
Efficacy
D0
D0
10
DO
DO
11
3.
4. 5. 6.
There is no toxicity
-cytotoxicity: human keratinocytes and human fibroblasts : NO -Ames test (geno toxicity) . NO -Eyes irritation text /HET-CAM test (Hens Egg Test-Chorio Allantioc Membrane)
and NRU: (Mouse Fibroblast Neural Red Uptake TEst): NO EYES IRRITATION
-LD50 rats: > 2.500 mg/kg = strictly NO TOXICITY -Occlusive patch tests on human skin : NOT IRRITATIVE -Intraepidermal abrasion + occlusive application: NOT IRRITATIVE (0 / max score 8) -HRIPT (Human Repeated Insult Patch Test) -Hemolysis test : NOT HEMOLYTIC -Subcutaneous injection (SNAP6) rabbits: Extremely low irritating power ( 0.55 on a 0 to 8 score) -Intraperitoneal injection (snap 6): 1-100 mg/kg: NO TOXICITY
13
Classical Mesotherapy
(CE as medical device pending)
Botox prolongator
No needle mesotherapy
Meso botox is less efficient than classical botox, except if similar doses are used BoNtA-like 5-6-8 will have the same level of efficacy than low doses meso botox BoNtA-like 5-6-8 are absolutely not toxic CE for injection pending
NO PALSY will occur, the skin will be relaxed, no risk of blepharochalasis, or eyebrows ptosis No risk of headache or other side effect linked to botulinic toxin injection
BoNtA-like 5-6-8
Low sensibility to oxidation: survive on the surface of the skin Low molecular weight: simple transcutaneous penetration has been proven (Franz Cell)
Chamber 2
After 2H: 36% of chamber 1 passed in chamber 2 After 4H: 48% Ch 1 After 6H: 78% Human Skin After 24H: 90%
Ch 2
17
2- Product application Apply the product on the skin Cover using a kling film ( Avoids Evaporation) Let the active products penetrate into the dermis
Or
More complex mixture ( see later) 4- cover with kling film . Intradermal penetration 5- intracellular penetration: Excellderm . Action every day
6- repeat 2 times month ( 4 sessions total) and use BoNtA daily care
1- Action potential
axone
3- SNARE complex formation 4- attraction of Ach vesicle to axone membrane 5- Membranes
ACh Vesicle
6- liberation of ACh in synaptic cleft 7- activation of muscle receptors
fusion
Synaptic Cleft
Muscle
8- Muscle contractions =>wrinkles
BoNtA 568 www.aestheticdermal.com 22
Neurotransmitter
Muscle
Goal can This is: neurotransmitter be done thanks to has membrane to pass through fusion porosome mechanism
SNAP-25 SyNaptosomal Associated Protein
23
Neurotransmitter
Muscle
SNARE = SNAp REceptor SNAP-25 or SyNaptosomal Associated Soluble N-ethylaleimideProtein sensitive fusion factor Attachment proteins REceptors
24
In response to a motor action potential, the 3 proteins (VAMP- Syntaxin and SNAP 25) combine and form a four helix protein complex called SNARE
This combination captures the neurotransmitter-filled vesicle, attract it and dock them very close to the synaptic membrane
But there is still water molecules [Ca(H20)n]2+ between the 2 bilayers and fusion is not possible as it BoNtA 568 www.aestheticdermal.com 25
Thanks to proteinic helix torsion forces, vesicle membrane and axone bilayer membranes are brought to within 2-3 Angtrms of each other. This allows calcium phosphate bridges between the 2 (-) surfaces Vesicle-axonal plasmatic membrane that usually repel each other [Ca(H20)n]2+ is more than 6 Angstrms => is physically explused
BoNtA 568 www.aestheticdermal.com 26
Ca-P bridges simply expel the water still separing vesicle membrane and
axon plasmatic membrane The little space left now between the 2 bilayers also displaces water bound to the P group of phospholipids => membrane destabilization and fusion
BoNtA 568 www.aestheticdermal.com 27
Membranes fusion
Synaptic cleft
Muscle membrane receptor Ach sensitive
28
How can BoNtA and BoNtA-like oligopeptides Interfere with this mechanism ?
All serotypes of Botulic Neutotoxins type A (BoNtA) are known polypeptides 2 PHASES OF ACTIVATION ARE NEEDED FOR A NEUROTOXICITY
30
31
32
X
BoNtA 568 www.aestheticdermal.com 33
The actual trend to use transdermal therapies without injections has led to the creation of new products derived from BoNtA: oligopeptides BoNtA like
They do not block the muscle completely as do BoNtA but, acting at the level of SNARE complex, they MODULATE muscle contraction, giving a relaxation effect
36
Types of peptides
Pentapeptide 3 (5 amino acids) acts as an inhibitory enkephalin Acetyl Hexapeptide 3 (6 amino acids) competitor for SNAP 25 protein Octopeptide or SNAP-8 (8 amino acids) competitor for SNAP 25 protein
=> The name oligopeptides BoNtA Like 5-6-8)
BoNtA 568 www.aestheticdermal.com 37
Pentapeptide
Pentapeptide 3 is a modified enkephalin that couples to enkephalin receptors on the outer membrane of axons, that are coupled to a Gi protein (inhibitory G protein). Stimulation of Gi receptors => Ca channel are closed and K channels are opened. Membrane fusion is a process strictly Ca dependent BoNtA 568 38 => less ACh exocytose. =>www.aestheticdermal.com REDUCTION OF NEURON EXCITABILITY
SNAP 6 or 8
Axone POROSOME
40
Exocytosis of catecholamines from chromaffines cells monotor release of catecholamins (adrenalin noradrenalin)
SNARE complex cannot be formed correctly in presence of SNAP 6 or SNAP 8 (proteins electrophoresis) SNARE complex formation in vitro
BoNtA 568 www.aestheticdermal.com 42
SNAP 8 (octopeptide) is more effective than SNAP6 (Acetyl Hexapeptide 3) in SNARE formation inhibition in vitro
43
Thank you
For Your attention
Dr Philippe Deprez
National Academy of Sciences - Bucuresti Honour member
Ed dunitz English version (450pp) available february 2007 Korean version (600pp): available septembre 2006 See on www.estetik.com
BoNtA 568 www.aestheticdermal.com